|
Volumn 53, Issue 1, 2010, Pages 214-215
|
Duration of diabetes, glucose control and cardiovascular risk
|
Author keywords
Cardiovascular risk; Intensive glucose control; Type 2 diabetes mellitus
|
Indexed keywords
GLICLAZIDE;
GLUCOSE;
HEMOGLOBIN A1C;
INDAPAMIDE PLUS PERINDOPRIL;
INSULIN;
AGE DISTRIBUTION;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
DISEASE COURSE;
DISEASE DURATION;
GLUCOSE BLOOD LEVEL;
GLYCEMIC CONTROL;
HEART FAILURE;
HEART INFARCTION;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
HYPOGLYCEMIA;
LETTER;
MICROANGIOPATHY;
MORTALITY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
SEX DIFFERENCE;
STROKE;
SUDDEN DEAFNESS;
BLOOD GLUCOSE;
CARDIOVASCULAR DISEASES;
DIABETES MELLITUS, TYPE 2;
DIABETIC ANGIOPATHIES;
HOMEOSTASIS;
HUMANS;
MYOCARDIAL INFARCTION;
RISK ASSESSMENT;
|
EID: 72449179846
PISSN: 0012186X
EISSN: 14320428
Source Type: Journal
DOI: 10.1007/s00125-009-1563-9 Document Type: Letter |
Times cited : (6)
|
References (5)
|